Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$95.88 - $117.08 $1.33 Million - $1.63 Million
-13,910 Closed
0 $0
Q3 2021

Oct 15, 2021

SELL
$84.42 - $106.62 $4,221 - $5,331
-50 Reduced 0.36%
13,910 $1.34 Million
Q1 2020

Apr 15, 2020

BUY
$49.46 - $64.78 $9,892 - $12,956
200 Added 1.45%
13,960 $840,000
Q4 2019

Jan 14, 2020

BUY
$49.86 - $58.26 $19,944 - $23,304
400 Added 2.99%
13,760 $796,000
Q3 2019

Oct 25, 2019

BUY
$47.54 - $53.43 $40,409 - $45,415
850 Added 6.79%
13,360 $691,000
Q2 2019

Jul 26, 2019

BUY
$46.79 - $52.47 $325,190 - $364,666
6,950 Added 125.0%
12,510 $639,000
Q1 2019

Apr 29, 2019

BUY
$46.36 - $52.63 $28,975 - $32,893
625 Added 12.66%
5,560 $291,000
Q4 2018

Jan 29, 2019

BUY
$41.54 - $47.25 $204,999 - $233,178
4,935 New
4,935 $227,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $252B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Taylor, Cottrill, Erickson & Associates, Inc. Portfolio

Follow Taylor, Cottrill, Erickson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.